Heart failure & cardiomyopathiesCohort study

Prognostic value of cardiac magnetic resonance global T2 mapping in patients with takotsubo syndrome

Eur Heart J Cardiovasc ImagingPublished

  • retrospective
  • consecutive TTS patients
  • imaging re-analysed, blinded to clinical data

Authors' conclusion

Global myocardial T2 may provide incremental prognostic information beyond prespecified clinical and imaging indices in TTS and refine risk stratification.

Study context

Population
Takotsubo syndrome (TTS) patients undergoing cardiac magnetic resonance (CMR) with tissue mapping within 30 days of admissionmedian age 68 years, 91% women
Participants
110 participants
Exposure
Global myocardial T2 and MACE
Outcome
MACE:
  • All-cause death
  • Heart failure hospitalization
  • Recurrent TTS
  • Stroke
  • Transient ischaemic attack
Follow-up
Median 763 days (IQR 525-1357)

Main finding

As reported in the abstract

each 5 ms increase in global T2Hazard ratio (95% CI)P value
ridge-penalized Cox models
1.40(1.06–1.87)
P = 0.020
after adjustment in the Firth-penalized model
1.70(1.20–2.40)
P = 0.004

Each 5 ms increase in global T2, as printed

experienced MACE
17 (15.5%)

Observational data: associations, not effects.

Further findings

Global T2

median global T2
56 ms (IQR 53-60)

T2 ≥ 63 ms for 1-year MACE

AUC
0.671
sensitivity
56%
specificity
89%
Kaplan-Meier curves separated
log-rank P = 0.003
  • internally derived threshold
  • modest 1-year discrimination

Original publication

Prognostic value of cardiac magnetic resonance global T2 mapping in patients with takotsubo syndrome. Eur Heart J Cardiovasc Imaging. Published 7 September 2026. doi:10.1093/ehjci/jeag243

Summarised from the published abstract; every number is checked against it